SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-20-023787
Filing Date
2020-12-17
Accepted
2020-12-16 19:52:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 88766
  Complete submission text file 0001493152-20-023787.txt   90125
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Subject) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81115 | Film No.: 201393874
SIC: 2834 Pharmaceutical Preparations

Mailing Address 269 S. BEVERLY DR. #1315 BEVERLY HILLS CA 90212
Business Address
Schwartzberg Gil (Filed by) CIK: 0001472409 (see all company filings)

Type: SC 13G/A